A study reveals that one company has registered half of all existing patents associated with genes
In the past three decades interest has surged towards one of the smallest units possible to claim: DNA. A new study reveals that a single company has registered half of all existing patents associated with genes from marine species. Actors such as universities, government bodies, individuals, and hospitals located in only 10 countries accounted for 98% of the patents. Photo: J. Berg/Azote.
 

Attention to blue growth has created a race to claim economic rights on everything in the oceans, from territory to resources. In the past three decades, companies, universities, and other organizations have focused their interest towards one of the smallest units possible to claim: DNA. Marine organisms have the ability to thrive in extremes of pressure, temperate, and chemistry; meaning their DNA could have important implications for humans, such as through biomedical and industrial applications.

However, ownership of associated patents linked to genetic material raises questions about equity and sustainability in working towards the Sustainable Development Goals.

Researchers from Stockholm Resilience Centre and University of British Columbia have published a study in Science Advances which examines who owns what in terms of marine genetic resources. The study highlights the need for greater transparency and equity of patent ownership and activities with respect to marine genetic resources and biodiversity.

More information: www.stockholmresilience.org 

The article: “Corporate control and global governance of marine genetic resources”